Formed in 2007, INDS consists of an innovative, experienced team with specialized, complementary expertise that delivers professional pharmaceutical and device development consulting and information technology solutions. Our nonclinical development experts provide cost- and time-efficient drug and device development program designs, program management, safety issue analysis and resolution strategies, regulatory submission preparation, and due diligence services. The INDS toxicology team has experience in all major therapeutic areas, applies innovative approaches to discovery support, and effectively designs and executes both traditional and novel development paradigms facilitating both IND submission and post-IND clinical development. INDS scientists have a proven record of developing ground-breaking medicines.